Zepp Health Corporation Sponsored ADR (NYSE:ZEPP) Sees Significant Increase in Short Interest

Key Points

• Short interest in Zepp Health Corporation rose by 157.6% in July, reaching a total of 308,600 shares from 119,800 shares in June.
• Analysts from Fundamental Research set a $13.87 price objective for Zepp Health and rated the stock as a "buy."
• The company's recent quarterly earnings showed a loss of ($1.13) per share with a revenue of $38.54 million.

Zepp Health Corporation Sponsored ADR (NYSE:ZEPP - Get Free Report) saw a significant increase in short interest during the month of July. As of July 15th, there was short interest totaling 308,600 shares, anincreaseof157.6% from the June 30th total of 119,800 shares. Based on an average trading volume of 453,900 shares, the short-interest ratio is currently 0.7 days. Currently,4.4% of the shares of the stock are sold short. Currently,4.4% of the shares of the stock are sold short. Based on an average trading volume of 453,900 shares, the short-interest ratio is currently 0.7 days.

Zepp Health Trading Down 3.9%

Shares of NYSE:ZEPP traded down $1.00 during trading on Thursday, hitting $24.34. 573,843 shares of the company's stock were exchanged, compared to its average volume of 246,664. The firm has a market cap of $352.86 million, a P/E ratio of -5.06 and a beta of 1.11. The firm has a 50-day moving average price of $7.05 and a two-hundred day moving average price of $4.27. The company has a current ratio of 1.10, a quick ratio of 0.84 and a debt-to-equity ratio of 0.31. Zepp Health has a 1-year low of $2.13 and a 1-year high of $27.86.

Zepp Health (NYSE:ZEPP - Get Free Report) last issued its quarterly earnings data on Monday, May 19th. The company reported ($1.13) earnings per share (EPS) for the quarter. The firm had revenue of $38.54 million for the quarter. Zepp Health had a negative net margin of 38.81% and a negative return on equity of 24.19%.

Analyst Ratings Changes

Separately, Fundamental Research set a $13.87 target price on shares of Zepp Health and gave the stock a "buy" rating in a research note on Tuesday, April 22nd.

Zepp Health Company Profile

Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura.